...
首页> 外文期刊>Pharmaceutical technology >US-EU Comparative Analysis and Interpretations
【24h】

US-EU Comparative Analysis and Interpretations

机译:美欧比较分析与解释

获取原文
获取原文并翻译 | 示例
           

摘要

There are significant differences between the United States and European Union requirements for the annual review of records related to the manufacturing and control for pharmaceutical products and actiwe pharmaceutical Ingredients, These different requirements mean that companies with international supply chains face the task of preparing separate reviews or combining the requirements of both regions to comply with EU and US good manufacturing practices.This article compares the requirements for the annual review between the US and EU?analyzes some of the major differences, and provides Interpretations and recommendations for several rewiew requirements.
机译:美国和欧盟对与药品和活性药物成分的生产和控制相关的记录进行年度审核的要求之间存在显着差异。这些不同要求意味着具有国际供应链的公司将面临准备单独审核或结合两个地区的要求以符合欧盟和美国的良好生产规范。本文比较了美国和欧盟之间的年度审核要求,分析了一些主要差异,并提供了一些建议和解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号